Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Serum and tissue biomarkers in aortic stenosis.

Global cardiology science & practice

Kapelouzou A, Tsourelis L, Kaklamanis L, Degiannis D, Kogerakis N, Cokkinos DV.
PMID: 26779524
Glob Cardiol Sci Pract. 2015 Nov 13;2015(4):49. doi: 10.5339/gcsp.2015.49. eCollection 2015.

BACKGROUND: Calcific aortic valve stenosis (CAVS) is seen in a large proportion of individuals over 60 years. It is an active process, influenced by lipid accumulation, mechanical stress, inflammation, and abnormal extracellular matrix turnover. Various biomarkers (BMs) are studied,...

Cite
Kapelouzou A, Tsourelis L, Kaklamanis L, et al. Serum and tissue biomarkers in aortic stenosis. Glob Cardiol Sci Pract. 2015;2015(4):49doi: 10.5339/gcsp.2015.49.
Kapelouzou, A., Tsourelis, L., Kaklamanis, L., Degiannis, D., Kogerakis, N., & Cokkinos, D. V. (2015). Serum and tissue biomarkers in aortic stenosis. Global cardiology science & practice, 2015(4), 49. https://doi.org/10.5339/gcsp.2015.49
Kapelouzou, Alkistis, et al. "Serum and tissue biomarkers in aortic stenosis." Global cardiology science & practice vol. 2015,4 (2015): 49. doi: https://doi.org/10.5339/gcsp.2015.49
Kapelouzou A, Tsourelis L, Kaklamanis L, Degiannis D, Kogerakis N, Cokkinos DV. Serum and tissue biomarkers in aortic stenosis. Glob Cardiol Sci Pract. 2015 Nov 13;2015(4):49. doi: 10.5339/gcsp.2015.49. eCollection 2015. PMID: 26779524; PMCID: PMC4710866.
Copy Download .nbib Format: NLM
WITHDRAWN: Identification of meteorin and metrnl as two novel pro-differentiative adipokines: Possible roles in controlling adipogenesis and insulin sensitivity.

Biochemical and biophysical research communications

Vezyraki A, Kapelouzouc S, Fotiadisb N, Theofilogiannakosa MS, Gerou E.
PMID: 23860268
Biochem Biophys Res Commun. 2013 Jul 13; doi: 10.1016/j.bbrc.2013.07.008. Epub 2013 Jul 13.

BBRC has been targeted by a scheme to defraud our editors, reviewers and readers with submission of a manuscript with falsified author and institutional information and therefore wholly unverifiable scientific claims. The manuscript has been withdrawn. We consider such...

Cite
Vezyraki A, Kapelouzouc S, Fotiadisb N, et al. WITHDRAWN: Identification of meteorin and metrnl as two novel pro-differentiative adipokines: Possible roles in controlling adipogenesis and insulin sensitivity. Biochem Biophys Res Commun. 2013;doi: 10.1016/j.bbrc.2013.07.008.
Vezyraki, A., Kapelouzouc, S., Fotiadisb, N., Theofilogiannakosa, M. S., & Gerou, E. (2013). WITHDRAWN: Identification of meteorin and metrnl as two novel pro-differentiative adipokines: Possible roles in controlling adipogenesis and insulin sensitivity. Biochemical and biophysical research communications, . https://doi.org/10.1016/j.bbrc.2013.07.008
Vezyraki, Alkistis, et al. "WITHDRAWN: Identification of meteorin and metrnl as two novel pro-differentiative adipokines: Possible roles in controlling adipogenesis and insulin sensitivity." Biochemical and biophysical research communications vol. (2013). doi: https://doi.org/10.1016/j.bbrc.2013.07.008
Vezyraki A, Kapelouzouc S, Fotiadisb N, Theofilogiannakosa MS, Gerou E. WITHDRAWN: Identification of meteorin and metrnl as two novel pro-differentiative adipokines: Possible roles in controlling adipogenesis and insulin sensitivity. Biochem Biophys Res Commun. 2013 Jul 13; doi: 10.1016/j.bbrc.2013.07.008. Epub 2013 Jul 13. PMID: 23860268.
Copy Download .nbib Format: NLM
The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ).

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Halapas A, Kapelouzou A, Chrissoheris M, Pattakos G, Cokkinos DV, Spargias K.
PMID: 33617961
Hellenic J Cardiol. 2021 Nov-Dec;62(6):423-428. doi: 10.1016/j.hjc.2021.02.003. Epub 2021 Feb 20.

BACKGROUND: Remote ischemic preconditioning (RIPC) is being evaluated as a strategy to reduce cardiac injury and inflammation in patients undergoing diverse cardiac invasive and surgical procedures. However, it is unclear whether RIPC has protective effects in patients undergoing the...

Cite
Halapas A, Kapelouzou A, Chrissoheris M, et al. The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic J Cardiol. 2021;62(6):423-428doi: 10.1016/j.hjc.2021.02.003.
Halapas, A., Kapelouzou, A., Chrissoheris, M., Pattakos, G., Cokkinos, D. V., & Spargias, K. (2021). The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 62(6), 423-428. https://doi.org/10.1016/j.hjc.2021.02.003
Halapas, Antonios, et al. "The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ)." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 62,6 (2021): 423-428. doi: https://doi.org/10.1016/j.hjc.2021.02.003
Halapas A, Kapelouzou A, Chrissoheris M, Pattakos G, Cokkinos DV, Spargias K. The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic J Cardiol. 2021 Nov-Dec;62(6):423-428. doi: 10.1016/j.hjc.2021.02.003. Epub 2021 Feb 20. PMID: 33617961.
Copy Download .nbib Format: NLM
Feasibility and Short-Term Outcomes of Three-Dimensional Hand-Sewn Esophago-Jejunal Anastomosis in Completely Laparoscopic Total Gastrectomy for Cancer.

Cancers

Charalabopoulos A, Davakis S, Paraskeva P, Machairas N, Kapelouzou A, Kordzadeh A, Sakarellos P, Vailas M, Baili E, Bakoyiannis C, Felekouras E.
PMID: 34572936
Cancers (Basel). 2021 Sep 20;13(18). doi: 10.3390/cancers13184709.

Laparoscopic total gastrectomy is on the rise. One of the most technically demanding steps of the approach is the construction of esophago-jejunal anastomosis. Several laparoscopic anastomotic techniques have been described, like linear stapler side-to-side or circular stapler end-to-side anastomosis;...

Cite
Charalabopoulos A, Davakis S, Paraskeva P, et al. Feasibility and Short-Term Outcomes of Three-Dimensional Hand-Sewn Esophago-Jejunal Anastomosis in Completely Laparoscopic Total Gastrectomy for Cancer. Cancers (Basel). 2021;13(18)doi: 10.3390/cancers13184709.
Charalabopoulos, A., Davakis, S., Paraskeva, P., Machairas, N., Kapelouzou, A., Kordzadeh, A., Sakarellos, P., Vailas, M., Baili, E., Bakoyiannis, C., & Felekouras, E. (2021). Feasibility and Short-Term Outcomes of Three-Dimensional Hand-Sewn Esophago-Jejunal Anastomosis in Completely Laparoscopic Total Gastrectomy for Cancer. Cancers, 13(18), . https://doi.org/10.3390/cancers13184709
Charalabopoulos, Alexandros, et al. "Feasibility and Short-Term Outcomes of Three-Dimensional Hand-Sewn Esophago-Jejunal Anastomosis in Completely Laparoscopic Total Gastrectomy for Cancer." Cancers vol. 13,18 (2021). doi: https://doi.org/10.3390/cancers13184709
Charalabopoulos A, Davakis S, Paraskeva P, Machairas N, Kapelouzou A, Kordzadeh A, Sakarellos P, Vailas M, Baili E, Bakoyiannis C, Felekouras E. Feasibility and Short-Term Outcomes of Three-Dimensional Hand-Sewn Esophago-Jejunal Anastomosis in Completely Laparoscopic Total Gastrectomy for Cancer. Cancers (Basel). 2021 Sep 20;13(18). doi: 10.3390/cancers13184709. PMID: 34572936; PMCID: PMC8468311.
Copy Download .nbib Format: NLM
The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ).

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Halapas A, Kapelouzou A, Chrissoheris M, Pattakos G, Cokkinos DV, Spargias K.
PMID: 33617961
Hellenic J Cardiol. 2021 Nov-Dec;62(6):423-428. doi: 10.1016/j.hjc.2021.02.003. Epub 2021 Feb 20.

BACKGROUND: Remote ischemic preconditioning (RIPC) is being evaluated as a strategy to reduce cardiac injury and inflammation in patients undergoing diverse cardiac invasive and surgical procedures. However, it is unclear whether RIPC has protective effects in patients undergoing the...

Cite
Halapas A, Kapelouzou A, Chrissoheris M, et al. The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic J Cardiol. 2021;62(6):423-428doi: 10.1016/j.hjc.2021.02.003.
Halapas, A., Kapelouzou, A., Chrissoheris, M., Pattakos, G., Cokkinos, D. V., & Spargias, K. (2021). The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 62(6), 423-428. https://doi.org/10.1016/j.hjc.2021.02.003
Halapas, Antonios, et al. "The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ)." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 62,6 (2021): 423-428. doi: https://doi.org/10.1016/j.hjc.2021.02.003
Halapas A, Kapelouzou A, Chrissoheris M, Pattakos G, Cokkinos DV, Spargias K. The effect of Remote Ischemic Preconditioning (RIPC) on myocardial injury and inflammation in patients with severe aortic valve stenosis undergoing Transcatheter Aortic Valve Replacement (TAVΙ). Hellenic J Cardiol. 2021 Nov-Dec;62(6):423-428. doi: 10.1016/j.hjc.2021.02.003. Epub 2021 Feb 20. PMID: 33617961.
Copy Download .nbib Format: NLM
The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.

European review for medical and pharmacological sciences

Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas KS, Kapelouzou A, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC.
PMID: 34982438
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623.

OBJECTIVE: Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome. Colchicine is an anti-inflammatory agent that inhibits inflammasome's action and stabilizes atherosclerotic lesions. N-acetylcysteine (NAC) reduces...

Cite
Spartalis M, Siasos G, Mastrogeorgiou M, et al. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021;25(24):7765-7776doi: 10.26355/eurrev_202112_27623.
Spartalis, M., Siasos, G., Mastrogeorgiou, M., Spartalis, E., Kaminiotis, V. V., Mylonas, K. S., Kapelouzou, A., Kontogiannis, C., Doulamis, I. P., Toutouzas, K., Nikiteas, N., & Iliopoulos, D. C. (2021). The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. European review for medical and pharmacological sciences, 25(24), 7765-7776. https://doi.org/10.26355/eurrev_202112_27623
Spartalis, M, et al. "The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits." European review for medical and pharmacological sciences vol. 25,24 (2021): 7765-7776. doi: https://doi.org/10.26355/eurrev_202112_27623
Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas KS, Kapelouzou A, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623. PMID: 34982438.
Copy Download .nbib Format: NLM
The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.

European review for medical and pharmacological sciences

Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas K, Kapelouzou KA, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC.
PMID: 34982438
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623.

OBJECTIVE: Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome. Colchicine is an anti-inflammatory agent that inhibits inflammasome's action and stabilizes atherosclerotic lesions. N-acetylcysteine (NAC) reduces...

Cite
Spartalis M, Siasos G, Mastrogeorgiou M, et al. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021;25(24):7765-7776doi: 10.26355/eurrev_202112_27623.
Spartalis, M., Siasos, G., Mastrogeorgiou, M., Spartalis, E., Kaminiotis, V. V., Mylonas, K., Kapelouzou, K. A., Kontogiannis, C., Doulamis, I. P., Toutouzas, K., Nikiteas, N., & Iliopoulos, D. C. (2021). The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. European review for medical and pharmacological sciences, 25(24), 7765-7776. https://doi.org/10.26355/eurrev_202112_27623
Spartalis, M, et al. "The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits." European review for medical and pharmacological sciences vol. 25,24 (2021): 7765-7776. doi: https://doi.org/10.26355/eurrev_202112_27623
Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas K, Kapelouzou KA, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623. PMID: 34982438.
Copy Download .nbib Format: NLM
Alterations in Toll-Like Receptor 7 and -9 mRNA Levels in Lungs after Ovariohysterectomy in a Pyometra Mouse Model.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes

Kyriakopoulos K, Katsimpoulas M, Mylonas KS, Lidoriki I, Ziogas IA, Perivolioti EP, Stamataki DK, Chrelias C, Schizas D, Alexandrou A, Liakakos T, Kapelouzou A.
PMID: 34959241
Eur Surg Res. 2021 Dec 27;1-13. doi: 10.1159/000519425. Epub 2021 Dec 27.

BACKGROUND: Pyometra (P) leads to sepsis and multiple organ dysfunction syndrome. Toll-like receptors (TLRs) recognize pathogens which can cause P. The aim of this study was to investigate TLR-7 and -9 via the MYD88 pathway and the nuclear factor...

Cite
Kyriakopoulos K, Katsimpoulas M, Mylonas KS, et al. Alterations in Toll-Like Receptor 7 and -9 mRNA Levels in Lungs after Ovariohysterectomy in a Pyometra Mouse Model. Eur Surg Res. 2021;1-13doi: 10.1159/000519425.
Kyriakopoulos, K., Katsimpoulas, M., Mylonas, K. S., Lidoriki, I., Ziogas, I. A., Perivolioti, E. P., Stamataki, D. K., Chrelias, C., Schizas, D., Alexandrou, A., Liakakos, T., & Kapelouzou, A. (2021). Alterations in Toll-Like Receptor 7 and -9 mRNA Levels in Lungs after Ovariohysterectomy in a Pyometra Mouse Model. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1-13. https://doi.org/10.1159/000519425
Kyriakopoulos, Konstantinos, et al. "Alterations in Toll-Like Receptor 7 and -9 mRNA Levels in Lungs after Ovariohysterectomy in a Pyometra Mouse Model." European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes vol. (2021): 1-13. doi: https://doi.org/10.1159/000519425
Kyriakopoulos K, Katsimpoulas M, Mylonas KS, Lidoriki I, Ziogas IA, Perivolioti EP, Stamataki DK, Chrelias C, Schizas D, Alexandrou A, Liakakos T, Kapelouzou A. Alterations in Toll-Like Receptor 7 and -9 mRNA Levels in Lungs after Ovariohysterectomy in a Pyometra Mouse Model. Eur Surg Res. 2021 Dec 27;1-13. doi: 10.1159/000519425. Epub 2021 Dec 27. PMID: 34959241.
Copy Download .nbib Format: NLM
KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model.

Annals of vascular surgery

Mylonas KS, Kapelouzou A, Spartalis M, Mastrogeorgiou M, Spartalis E, Bakoyiannis C, Liakakos T, Schizas D, Iliopoulos D, Nikiteas N.
PMID: 34182114
Ann Vasc Surg. 2022 Jan;78:328-335. doi: 10.1016/j.avsg.2021.04.040. Epub 2021 Jun 26.

BACKGROUND: Inflammatory dysregulation of KLF4 is related to atheromatosis. In the present study, we explored the impact of colchicine-based regimens on the development of thoracic aortic atheromatosis and KLF4 expression.METHODS: Twenty-eight New Zealand White rabbits were divided to 4...

Cite
Mylonas KS, Kapelouzou A, Spartalis M, et al. KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Ann Vasc Surg. 2021;78:328-335doi: 10.1016/j.avsg.2021.04.040.
Mylonas, K. S., Kapelouzou, A., Spartalis, M., Mastrogeorgiou, M., Spartalis, E., Bakoyiannis, C., Liakakos, T., Schizas, D., Iliopoulos, D., & Nikiteas, N. (2022). KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Annals of vascular surgery, 78328-335. https://doi.org/10.1016/j.avsg.2021.04.040
Mylonas, Konstantinos S, et al. "KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model." Annals of vascular surgery vol. 78 (2022): 328-335. doi: https://doi.org/10.1016/j.avsg.2021.04.040
Mylonas KS, Kapelouzou A, Spartalis M, Mastrogeorgiou M, Spartalis E, Bakoyiannis C, Liakakos T, Schizas D, Iliopoulos D, Nikiteas N. KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Ann Vasc Surg. 2022 Jan;78:328-335. doi: 10.1016/j.avsg.2021.04.040. Epub 2021 Jun 26. PMID: 34182114.
Copy Download .nbib Format: NLM
KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model.

Annals of vascular surgery

Mylonas KS, Kapelouzou A, Spartalis M, Mastrogeorgiou M, Spartalis E, Bakoyiannis C, Liakakos T, Schizas D, Iliopoulos D, Nikiteas N.
PMID: 34182114
Ann Vasc Surg. 2021 Jun 26; doi: 10.1016/j.avsg.2021.04.040. Epub 2021 Jun 26.

BACKGROUND: Inflammatory dysregulation of KLF4 is related to atheromatosis. In the present study, we explored the impact of colchicine-based regimens on the development of thoracic aortic atheromatosis and KLF4 expression.METHODS: Twenty-eight New Zealand White rabbits were divided to 4...

Cite
Mylonas KS, Kapelouzou A, Spartalis M, et al. KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Ann Vasc Surg. 2021;doi: 10.1016/j.avsg.2021.04.040.
Mylonas, K. S., Kapelouzou, A., Spartalis, M., Mastrogeorgiou, M., Spartalis, E., Bakoyiannis, C., Liakakos, T., Schizas, D., Iliopoulos, D., & Nikiteas, N. (2021). KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Annals of vascular surgery, . https://doi.org/10.1016/j.avsg.2021.04.040
Mylonas, Konstantinos S, et al. "KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model." Annals of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.avsg.2021.04.040
Mylonas KS, Kapelouzou A, Spartalis M, Mastrogeorgiou M, Spartalis E, Bakoyiannis C, Liakakos T, Schizas D, Iliopoulos D, Nikiteas N. KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model. Ann Vasc Surg. 2021 Jun 26; doi: 10.1016/j.avsg.2021.04.040. Epub 2021 Jun 26. PMID: 34182114.
Copy Download .nbib Format: NLM
The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.

European review for medical and pharmacological sciences

Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas K, Kapelouzou KA, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC.
PMID: 34982438
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623.

OBJECTIVE: Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome. Colchicine is an anti-inflammatory agent that inhibits inflammasome's action and stabilizes atherosclerotic lesions. N-acetylcysteine (NAC) reduces...

Cite
Spartalis M, Siasos G, Mastrogeorgiou M, et al. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021;25(24):7765-7776doi: 10.26355/eurrev_202112_27623.
Spartalis, M., Siasos, G., Mastrogeorgiou, M., Spartalis, E., Kaminiotis, V. V., Mylonas, K., Kapelouzou, K. A., Kontogiannis, C., Doulamis, I. P., Toutouzas, K., Nikiteas, N., & Iliopoulos, D. C. (2021). The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. European review for medical and pharmacological sciences, 25(24), 7765-7776. https://doi.org/10.26355/eurrev_202112_27623
Spartalis, M, et al. "The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits." European review for medical and pharmacological sciences vol. 25,24 (2021): 7765-7776. doi: https://doi.org/10.26355/eurrev_202112_27623
Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas K, Kapelouzou KA, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623. PMID: 34982438.
Copy Download .nbib Format: NLM
The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.

European review for medical and pharmacological sciences

Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas KS, Kapelouzou A, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC.
PMID: 34982438
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623.

OBJECTIVE: Atherosclerosis is a chronic inflammatory disease promoted by pro-inflammatory cytokines produced by NOD-, LRR- and pyrin domain-containing protein 3 (NLRP 3) inflammasome. Colchicine is an anti-inflammatory agent that inhibits inflammasome's action and stabilizes atherosclerotic lesions. N-acetylcysteine (NAC) reduces...

Cite
Spartalis M, Siasos G, Mastrogeorgiou M, et al. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021;25(24):7765-7776doi: 10.26355/eurrev_202112_27623.
Spartalis, M., Siasos, G., Mastrogeorgiou, M., Spartalis, E., Kaminiotis, V. V., Mylonas, K. S., Kapelouzou, A., Kontogiannis, C., Doulamis, I. P., Toutouzas, K., Nikiteas, N., & Iliopoulos, D. C. (2021). The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. European review for medical and pharmacological sciences, 25(24), 7765-7776. https://doi.org/10.26355/eurrev_202112_27623
Spartalis, M, et al. "The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits." European review for medical and pharmacological sciences vol. 25,24 (2021): 7765-7776. doi: https://doi.org/10.26355/eurrev_202112_27623
Spartalis M, Siasos G, Mastrogeorgiou M, Spartalis E, Kaminiotis VV, Mylonas KS, Kapelouzou A, Kontogiannis C, Doulamis IP, Toutouzas K, Nikiteas N, Iliopoulos DC. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7765-7776. doi: 10.26355/eurrev_202112_27623. PMID: 34982438.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries